202 related articles for article (PubMed ID: 17102040)
21. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
Rofsky NM; Earls JP
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance imaging of the liver: how I do it.
Semelka RC; Martin DR; Balci NC
J Gastroenterol Hepatol; 2006 Apr; 21(4):632-7. PubMed ID: 16677146
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance imaging contrast agents.
Runge VM
Curr Opin Radiol; 1992 Feb; 4(1):3-12. PubMed ID: 1739599
[TBL] [Abstract][Full Text] [Related]
24. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
[TBL] [Abstract][Full Text] [Related]
25. [MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
Ba-Ssalamah A; Happel B; Kettenbach J; Dirisamer A; Wrba F; Längle F; Schima W
Radiologe; 2004 Dec; 44(12):1170-84. PubMed ID: 15551031
[TBL] [Abstract][Full Text] [Related]
26. MR imaging of the liver. Technique.
Soyer P; Bluemke DA; Rymer R
Magn Reson Imaging Clin N Am; 1997 May; 5(2):205-21. PubMed ID: 9113672
[TBL] [Abstract][Full Text] [Related]
27. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Burke C; Alexander Grant L; Goh V; Griffin N
Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
[TBL] [Abstract][Full Text] [Related]
28. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Giovagnoni A; Paci E
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
[TBL] [Abstract][Full Text] [Related]
29. Cirrhosis and lesion characterization at MR imaging.
Hussain SM; Reinhold C; Mitchell DG
Radiographics; 2009 Oct; 29(6):1637-52. PubMed ID: 19959512
[TBL] [Abstract][Full Text] [Related]
30. Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver.
Marin D; Catalano C; Rossi M; Guerrisi A; Di Martino M; Berloco P; Passariello R
J Magn Reson Imaging; 2008 Sep; 28(3):755-8. PubMed ID: 18777536
[TBL] [Abstract][Full Text] [Related]
31. Focal liver lesion detection and characterization with GD-EOB-DTPA.
Purysko AS; Remer EM; Veniero JC
Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
[TBL] [Abstract][Full Text] [Related]
32. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions.
Pirovano G; Vanzulli A; Marti-Bonmati L; Grazioli L; Manfredi R; Greco A; Holzknecht N; Daldrup-Link HE; Rummeny E; Hamm B; Arneson V; Imperatori L; Kirchin MA; Spinazzi A
AJR Am J Roentgenol; 2000 Oct; 175(4):1111-20. PubMed ID: 11000175
[TBL] [Abstract][Full Text] [Related]
34. Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience.
Yeh BM; Breiman RS; Taouli B; Qayyum A; Roberts JP; Coakley FV
Radiology; 2004 Mar; 230(3):645-51. PubMed ID: 14990830
[TBL] [Abstract][Full Text] [Related]
35. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
36. T2-weighted MR imaging in the assessment of cirrhotic liver.
Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
[TBL] [Abstract][Full Text] [Related]
37. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
Wintersperger BJ; Runge VM; Tweedle MF; Jackson CB; Reiser MF
Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging.
Ito K
Eur J Radiol; 2006 May; 58(2):186-99. PubMed ID: 16413154
[TBL] [Abstract][Full Text] [Related]
39. Contrast agents for MR imaging of the liver.
Low RN
J Magn Reson Imaging; 1997; 7(1):56-67. PubMed ID: 9039594
[TBL] [Abstract][Full Text] [Related]
40. [Progress in magnetic resonance tomography of the liver: value of ultra-rapid imaging and liver-specific contrast media].
Reimer P; Rummeny EJ; Hamm B; Mühler A; Cavagna F; Saini S; Peters PE
Bildgebung; 1994 Mar; 61(1):5-13. PubMed ID: 8193519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
